Finerenone for kidney transplant recipients: the EFFEKTOR study
Treatments studied
Part of Heart & circulation, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether a medicine called finerenone can help protect kidney transplants from further damage. People who have had a kidney transplant and have protein in their urine may benefit from this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and had a kidney transplant 1 to 10 years ago.
- Your kidney function is stable, with a test result (eGFR) of 25 or higher.
- You have a small amount of protein (albumin) in your urine — a sign of kidney stress.
- You are not currently taking certain medications like spironolactone, eplerenone, or both an ACE inhibitor and an ARB together.
- You are willing to use effective birth control if you could become pregnant, or you are past menopause or have had certain surgeries.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if finerenone can protect kidneys in people with chronic kidney disease who are not taking common blood pressure medications called ACE inhibitors, ARBs, or renin inhibitors. It may help slow kidney damage.
This trial tests whether a drug called finerenone can help people recover from acute kidney injury (AKI), a sudden loss of kidney function. It might reduce further kidney damage and improve recovery.
This trial tests if a medicine called finerenone can protect kidney function in people with type 2 diabetes and early-to-moderate chronic kidney disease. It may be an option if you are already on blood pressure medication and have some protein in your urine.
This trial tests a medication called finerenone to see if it can lower the amount of protein in your urine, which is a sign of kidney damage. It is for people with type 2 diabetes and chronic kidney disease who are already on standard blood pressure medications.
This trial studies whether a drug called finerenone can safely and effectively treat kidney disease caused by type 2 diabetes. If you qualify, you would take finerenone while your regular diabetes and blood pressure medications continue unchanged.
This trial tests whether adding finerenone to your current diabetes medications can better protect your heart and kidneys. It is for people with type 2 diabetes who already take an SGLT2 inhibitor and an ACE inhibitor or ARB.
Hear when a new Kidney Transplant; Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.